RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
1167. Rostand SG, Gretes KC, Kirk KA, Rutsky EA,Andreoli TE.
Ischemic heart disease in patients with uremia undergoing
maintenance hemodialysis. Kidney Int 16:600-611, 1979.
1168. Amann U, Ritz E, Wiest G, Klaus G, Mall G. A role of
parathyroid hormone in the genesis of interstitial cell activation.
J Am Soc Nephrol 4:1814-1819, 1994.
1169. Vlahakos DV, Hahalis G, Vasillakos P, Marathias KP,
Geroulanos S. Relationship between left ventricular hpertrophy
and plasma renin activity in chronic hemodialysis
patients. J Am Soc Nephrol 8:1764-1770, 1997.
1170. Washio M, Okuda S, Mizoue T, Kiyama S, Ando T, Sanai T y
cols. Risk factors for left ventricular hypetrophy in chronic
hemodialysis patients. Clin Nephrol 47:362-366, 1997.
1171. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors
for the development of left ventricular hypertrophy in a
prospective followed cohort of dialysis patients. J Am Soc
Nephrol 1994;4:1486-1490, 1994.
1172. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S,
Cataliotti A y cols.; CREED Investigators. The Cardiovascular
Risk Extended Evaluation. Diagnostic potential of cardiac
natriuretic peptides in dialysis patients. Kidney Int 59:1559-
1566, 2001.
1173. Ozkahya M, Toz H, Özerkan F, Duman S, Ok E, Basci A y
cols. Impact of volume control on left ventricular hypertrophy
in dialysis patients. J Nephrol 15:655-660, 2002.
1174. Tucker B, Fabbian F,Giles M . Reduction of left ventricular
mass with blood pressure reduction in chronic renal failure.
Clin Nephrol 52:377-382, 1999.
1175. Roithinger FX, Punzengrubere C, Wallner M, Ulbrich W,
Pachinger O, Kramar R y cols. The influence of ACE inhibition
on myocardial mass and diastolic function in chronic
hemodialysis patients with adequate control of blood pressure.
Clin Nephrol 42:309-314, 1994.
1176. Portoles J, Torralbo A, Martin P, Rodrigo J, Herrero JA,
Barrientos A.Cardiovascular effects of recombinant human
erythropoietin in predialysis patients. Am J Kidney Dis
29:541-548, 1997.
1177. Wizemann V, Shafer R, Kramer W. Follow-up of cardiac
change in normotensive hemodialysis patients with left ventricular
hypertrophy. Nephron 69:202-206, 1993.
1178. Low-Friedrich I,Gruntzmacher P, Marz W, Bergmann M,
Schoeppe W. Therapy with recombinant human erythropoietin
reduces cardiac size and improves heart function in chronic
hemodialysis patients. Am J Nephrol 11:54-60, 1991.
1179. Pascual J, Teruel DL, Moya JL, Liano F, Jimenez-Mena M,
Ortuno J. Regression of left ventricular hypertrophy after partial
correction of anemia with erythropoietin in patients on
hemodialysis. Clin Nephrol 35:280-287, 1991.
1180. Massimetti C, Pontillo D, Feriozzi S, Costantini S, Capezzuto
A, Ancarani E. Impact of recombinant human erythropoietin
tretamente on left ventricular hypertrophy and cardiac function
in dialysis patients. Blood Purif 16:317-324, 1998.
1181. Rademacher J, Koch KM. Treatment of renal anemia by erythropoietin
substitution. The effects on the cardiovascular
system. Clin Nephrol 44 (suppl 1): 856-860, 1995.
1182. Kasiske BL,Cangro CB, Hariharan S, Hricik ED, Kerman RH,
Roth D y cols. The evaluation of renal transplantation candidates:
Clinical practice guidelines. Am J Transplant 1(suppl
2):1-95, 2002.
1183. Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM,
Deierhoi H, y cols. The report of a National Conference on
the wait list for kidney transplantation. Am J Transplant
3:775-785, 2003.
1184. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA.
Association between renal insufficiency and inducible ischemia
in patients with coronary artery disease: The Heart and
Soul Study. J Am Soc Nephrol 14:3233-3238, 2003.
1185. Rostand SG, Rutsky EA. Cardiac disease in dialysis patients.
In: Clinical Dialysis, 3rd ED, edited by Nissenson AR, Fine
RN, Gentile DE, Norwalk CT, Appleton and Lange. pp 652-
698, 1995.
1186. Manske CL, Wang Y, Rector T, Wilson RF, White CW.
Coronary revascularization in insulin-dependent diabetic
patients with chronic renal failure. Lancet 340:998-1002,
1992.
1187. Murphy SW, Foley RN, Parfrey RS. Screening and treatment
for cardiovascular disease in patients with chronic renal
disease. Am J Kidney Dis 32: S184-99, 1998.
1188. Controlling the epidemic of cardiovascular disease in chronic
renal disease: What do we know? What do we need to
know? Where do we go from here? Special report from the
National Kidney Foundation Task Force on Cardiovascular
Disease. Am J Kidney Dis 32 (suppl 3): S1-199, 1998.
1189. Zawada ET Jr, Stinson JB, Done G. New perspectives on
coronary artery disease in hemodialysis patients. South Med
J 75:694-6,1982.
1190. Elsner D. How to diagnose and treat coronary artery disease
in the uraemic patient: an update. Nephrol Dial Transplant
16:1103-8, 2001.
1191. Ridker P,Rifai N, Rose L,Buring JE, Cook NR. Comparison of
C-reactive protein and low-density lipoprotein cholesterol
levels in the prediction of first cardiovascular events. N Engl
J Med 347:1557-1565, 2002.
1192. Wanner C, Metzger T. C-reactive protein a marker for allcause
and cardiovascular mortality in haemodialysis
patients. Nephrol Dial Transplant 17 (suppl 8); 29-32, 2002.
1193. Stevinkel P, Alvestrand P. Inflammation in end-stage renal
disease: Sources, consequences and therapy. Seminar Dial
15:330-338, 2002.
1194. Herzog CA. How to manage the renal patient with coronary
heart disease: The Agony and the Ecstasy of Opinion-Based
Medicine. J Am Soc Nephrol 14:2556-2572, 2002.
1195. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive
value of cardiac troponin I and T for subsequent death in
end-stage renal disease. Circulation 106:2941-2945, 2002.
1196. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA,
Cutrupi S y cols. Troponin is related to left ventricular mass
and predicts all-cause and cardiovascular mortality in hemodialysis
patients. Am J Kidney Dis 40:68-75, 2002.
1197. Setsusa K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada
A y cols. Clinical significance of elevated levels of cardiac
troponin T in patients with chronic heart failure. Am J
Cardiol 84:608-611, 1999.
1198. Goicoechea M, Garcia de Vinuesa MS, Gómez-Campderá F,
Gutierrez MJ, Blanco P, Amann R y cols. Clinical significance
of cardiac troponin T levels in chronic kidney disease
patients: predictive value for cardiovascular risk. Am J
Kidney Dis 43:846-853, 2004.
1199. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman M
y cols. Troponin T levels in patients with acute coronary
syndromes with or without renal dysfunction. N Engl J Med
346:2047-2052, 2002.
223